| β-Coronaviruses use lysosomes for egress instead of the biosynthetic secretory pathway S Ghosh, TA Dellibovi-Ragheb, A Kerviel, E Pak, Q Qiu, M Fisher, ... Cell 183 (6), 1520-1535. e14, 2020 | 520 | 2020 |
| A PCBP1–BolA2 chaperone complex delivers iron for cytosolic [2Fe–2S] cluster assembly SJ Patel, AG Frey, DJ Palenchar, S Achar, KZ Bullough, A Vashisht, ... Nature chemical biology 15 (9), 872-881, 2019 | 94 | 2019 |
| CD19/22 CAR T cells in children and young adults with B-ALL: phase 1 results and development of a novel bicistronic CAR H Shalabi, H Qin, A Su, B Yates, PL Wolters, SM Steinberg, JA Ligon, ... Blood, The Journal of the American Society of Hematology 140 (5), 451-463, 2022 | 66 | 2022 |
| Universal antigen encoding of T cell activation from high-dimensional cytokine dynamics SR Achar, FXP Bourassa, TJ Rademaker, A Lee, T Kondo, ... Science 376 (6595), 880-884, 2022 | 34 | 2022 |
| T cell receptor and IL-2 signaling strength control memory CD8+ T cell functional fitness via chromatin remodeling SS Chin, E Guillen, L Chorro, S Achar, K Ng, S Oberle, F Alfei, D Zehn, ... Nature communications 13 (1), 2240, 2022 | 17 | 2022 |
| CD3ζ ITAMs enable ligand discrimination and antagonism by inhibiting TCR signaling in response to low-affinity peptides G Gaud, S Achar, FXP Bourassa, J Davies, T Hatzihristidis, S Choi, ... Nature immunology 24 (12), 2121-2134, 2023 | 2 | 2023 |
| Manufacture of CD22 CAR T cells following positive versus negative selection results in distinct cytokine secretion profiles and γδ T cell output HW Song, M Benzaoui, A Dwivedi, S Underwood, L Shao, S Achar, ... Molecular Therapy Methods & Clinical Development 32 (1), 2024 | | 2024 |
